Harnessing the potential of multimodal radiotherapy in prostate cancer -н Philippou, Y, Sjoberg, H, Lamb, AD, Camilleri, P, Bryant, RJ

“…Thus, radiotherapy is becoming a key component of multimodal therapy for many stages of prostate cancer, particularly oligometastatic disease.…”

Long-term quality of life in prostate cancer -н Hamdy, F

Imaging proteolysis in prostate cancer and stromal cells -н Molokwu, C, Adeniji, O, Hamdy, F, Buttle, D

Management of prostate cancer. Part 1: chemoprevention. -н Sooriakumaran, P

“…Numerous agents have been investigated in prostate cancer prevention. Many manipulate sex steroid levels or function, some regulate response to oxidative stress and others affect tumor proliferation and/or apoptosis. …”

Early diagnosis and surgical management of prostate cancer. -н Linton, K, Hamdy, F

“…Prostate cancer is a significant cause of morbidity and mortality in the United States and Europe. …”

Incidence, prevalence, and survival of prostate cancer in the UK -н Tan, EH, Burn, E, Barclay, NL, Delmestri, A, Man, WY, Golozar, A, Serrano, ÀR, Duarte-Salles, T, Cornford, P, Prieto Alhambra, D, Newby, D

“…<p><strong>Importance</strong> Incidence, prevalence, and survival are pertinent measures to inform the management and provision of prostate cancer care.</p> <p><strong>Objective</strong> To calculate the incidence, prevalence, and survival rates for prostate cancer in the UK from 2000 to 2021.…”

Lead time associated with screening for prostate cancer. -н Törnblom, M, Eriksson, H, Franzén, S, Gustafsson, O, Lilja, H, Norming, U, Hugosson, J

“…Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detection of prostate cancer (PC). Quantification of the lead time thus obtained is important both for understanding the development of PC and for evaluating the advantages and disadvantages of widespread screening. …”

Early diagnosis and surgical management of prostate cancer -н Linton, D, Hamdy, F

“…Prostate cancer is a significant cause of morbidity and mortality in the United States and Europe. …”

Nutritional and hormonal biomarkers in prostate cancer epidemiology -н Price, A, Alison Price

“…<p>Evidence from international comparisons and migrant studies suggest that environmental factors, such as a Western diet, may be important in prostate cancer development, possibly through effects on hormone and growth factor secretion and metabolism. …”

THE ROLE OF ACTIVE MONITORING IN THE MANAGEMENT OF PROSTATE CANCER -н Hamdy, F

10-year outcomes in localized prostate cancer. -н Hamdy, F, Donovan, J, Neal, D

“…The predetermined power calculation for the ProtecT trial estimated a prostate-cancer mortality rate of 10% at a median of 10 years, and because the observed rate was 1%, longer follow-up is required to evaluate differences. …”

Putting prostate cancer metabolism into the right context -н Mills, I

Expression and immunolocalisation of neutral endopeptidase in prostate cancer. -н Albrecht, M, Mittler, A, Wilhelm, B, Lundwall, A, Lilja, H, Aumüller, G, Bjartell, A

“…When present on androgen-dependent prostate cancer (PC) cells, NEP inactivates growth stimulatory neuropeptides. …”

ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY -н Dalesio, O, Peto, R, Schroder, F

Re: Effect of dutasteride on the risk of prostate cancer -н Sooriakumaran, P, Tewari, A

The role of glycans in the development and progression of prostate cancer -н Munkley, J, Mills, I, Elliott, D

“…Prostate cancer is a unique and heterogeneous disease. …”

Clinically localised prostate cancer is microsatellite stable. -н Azzouzi, A, Catto, J, Rehman, I, Larre, S, Roupret, M, Feeley, K, Cussenot, O, Meuth, M, Hamdy, F

“… OBJECTIVES: To determine the frequency of microsatellite instability (MSI) change with mono-, di- and tetranucleotide markers in clinically localized prostate cancer, and to correlate those markers with clinical and pathological variables. …”

Prostate cancer screening in the workplace. Employer costs. -н Snyder, C, Schrammel, P, Griffiths, C, Griffiths, R

“…Recognition of the mortality and morbidity associated with prostate cancer has resulted in employer based screening programs. …”

Prostate cancer: embodied experience and perceptions of masculinity -н Chapple, A, Ziebland, S

“…This paper looks at the way in which prostate cancer and its treatment affects men's bodies, their roles and sense of masculinity. …”

Prognostic value of serum markers for prostate cancer. -н Stenman, U, Abrahamsson, P, Aus, G, Lilja, H, Bangma, C, Hamdy, F, Boccon-Gibod, L, Ekman, P

“…The incidence of prostate cancer has increased dramatically during the last 10-15 years and it is now the commonest cancer in males in developed countries. …”